Literature DB >> 7499213

Identification of a novel repressive element in the proximal lck promoter.

R C Muise-Helmericks1, N Rosen.   

Abstract

The T-cell-specific protooncogene lck, a src-related tyrosine kinase, is under the control of two promoters that give rise to transcripts differing only in their 5'-untranslated regions. The distal promoter is transcriptionally active in both peripheral and thymic T-cells, whereas expression of the proximal promoter is highest in developing thymocytes. The proximal promoter has also been shown to be selectively activated in a number of colon carcinoma cell lines. Approximately 570 base pairs of proximal promoter sequence is required for expression in both T-cells and colon carcinoma cell lines. Protein binding studies were initiated with an oligonucleotide homologous to a region that, when deleted, causes an increase in promoter activity in transgenic animals. Two proteins with approximate molecular masses of 35 and 75 kDa were found to bind to this region as determined by UV cross-linking studies. Absence of specific protein binding is correlated with a high level of proximal promoter expression. Competitive gel retardation analysis identified a 9-base pair binding site within the proximal lck promoter that is necessary for repression of transcription in cells that contain specific binding activity. Mutants of this binding site do not repress transcription. Repression does not occur in a cell line that expresses lck and lacks this activity. These data support the hypothesis that activation of lck transcription in colon carcinoma is due, at least in part, to the loss of a transcriptional repressor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499213     DOI: 10.1074/jbc.270.46.27538

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  A novel animal model of thymic tumour: development of epithelial thymoma in transgenic rats carrying human T lymphocyte virus type I pX gene.

Authors:  Kazunori Kikuchi; Hitoshi Ikeda; Takahiro Tsuchikawa; Takahiro Tsuji; Satoshi Tanaka; Kazunori Fugo; Toshiaki Sugaya; Yuetsu Tanaka; Masatoshi Tateno; Naoki Maruyama; Takashi Yoshiki
Journal:  Int J Exp Pathol       Date:  2002-10       Impact factor: 1.925

2.  RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry.

Authors:  Cherilyn A Elwell; Alhaji Ceesay; Jung Hwa Kim; Daniel Kalman; Joanne N Engel
Journal:  PLoS Pathog       Date:  2008-03-07       Impact factor: 6.823

3.  The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.

Authors:  Annette V Jacobsen; Catia L Pierotti; Kym N Lowes; Amanda E Au; Ying Zhang; Nima Etemadi; Cheree Fitzgibbon; Wilhelmus J A Kersten; André L Samson; Mark F van Delft; David C S Huang; Hélène Jousset Sabroux; Guillaume Lessene; John Silke; James M Murphy
Journal:  Cell Death Dis       Date:  2022-04-01       Impact factor: 9.685

4.  NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia.

Authors:  Melanie Märklin; Jonas S Heitmann; Alexander R Fuchs; Felicia M Truckenmüller; Michael Gutknecht; Stefanie Bugl; Sebastian J Saur; Juliane Lazarus; Ursula Kohlhofer; Leticia Quintanilla-Martinez; Hans-Georg Rammensee; Helmut R Salih; Hans-Georg Kopp; Michael Haap; Andreas Kirschniak; Lothar Kanz; Anjana Rao; Stefan Wirths; Martin R Müller
Journal:  Nat Commun       Date:  2017-10-02       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.